What to Look For When UnitedHealth Reports on Tuesday Morning
UnitedHealth is scheduled to report its second-quarter financial results before the markets open on Tuesday.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 119
What to Expect When Johnson & Johnson Reports Tuesday
Johnson & Johnson is scheduled to report its third-quarter financial results early Tuesday, and analysts expect solid growth on the top and bottom lines.
Tetraphase Prepares for US Launch of Xerava
Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.
Why Corium Shares Are Booming
Corium shares jumped on Friday after the company announced that it entered into a definitive merger agreement under which Gurnet Point Capital will acquire Corium.
How Compugen Is Weathering Thursday’s Storm
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
CRISPR Wins FDA Approval for Human Trials
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Meet Ionis Pharma’s Newest Collaboration
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
Why AcelRx Is Jumping Despite FDA Update
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.
Short Sellers Run for Cover From Major Pharma
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Short Sellers Back Off Major Biotechs
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Mylan’s Mapi Collaboration for Multiple Sclerosis Doesn’t Seem to Be Paying Off
Mylan shares hit a 52-week low after Mapi Pharma announced midstage results from its multiple sclerosis trial.
Can This Clinical Hold Stop Affimed’s Momentum?
Affimed shares took a big step back early on Tuesday after the company announced that it has placed its AFM11 on clinical hold, and has notified the global health authorities of its decision.
Akcea Stumbles Over Newest Board Addition
Akcea Therapeutics shares pulled back on Monday after the company announced a big change to its board of directors.
Exelixis Initiates Key Late-Stage Cancer Trial
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
Major Biopharma Catalysts to Watch For in October
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the remainder of October.